Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ketamine and Clonidine for Diabetic Neuropathic Pain
NCT00661063Phase 3Unknown
- Sponsor
- Santa Casa de Misericórdia de São Paulo
- Start
- Apr 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine transdermal patch and clonidine in diabetic neuropathy (4 arms), sponsored by Santa Casa de Misericórdia de São Paulo. Primary endpoint: Pain evaluation by visual analogue scale at 12 weeks. Status: unknown.
02
Drugs
ketamine transdermal patchclonidine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00661063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661063.